Sort
25,944 grants matching “neurodegeneration”
BACE1 in neurodegeneration and neuronal dysfunction
$530,674Riqiang Yan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · NS
BACE1 in neurodegeneration and neuronal dysfunction
$530,674Riqiang Yan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · NS
Neuroscience of Aging, Neurodegeneration and Alzheimer's Disease
$530,665Jacob Raber · Oregon Health & Science University · T32 · FY2024 · AG
Resilience and Resistance Phenotypes
$530,363Susan Y Bookheimer · Boston University Medical Campus · U19 · FY2024 · AG
Viral Host Interactions in SIV Cardiac Dysfunction
$530,276Joseph L Mankowski · Johns Hopkins University · R01 · FY2006 · HL
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
$530,189David M Holtzman · Mayo Clinic Jacksonville · U19 · FY2023 · AG
Descending Modulation of Nerve Injury and Injury-Evoked Pain
$530,120Toni Shippenberg · National Institute On Drug Abuse · ZIA · FY2010 · DA
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
$530,070Robert W. Mahley · J. David Gladstone Institutes · U01 · FY2014 · AG
BACE1 in neurodegeneration and neuronal dysfunction
$530,047Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · R01 · FY2018 · NS
BACE1 in neurodegeneration and neuronal dysfunction
$530,047Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · R01 · FY2020 · NS
BACE1 in neurodegeneration and neuronal dysfunction
$530,047Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · R01 · FY2019 · NS
Protection from pathological tau by activation of the ER unfolded protein response
$530,011Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2020 · AG
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology
$530,006Maria F Braga · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2012 · NS
Metabolomic Signatures Linking ALS to Persistent Organic Pollutant Exposures
$530,000Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2020 · TS
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development
$529,901Nigel H. Greig · National Institute On Aging · ZIA · FY2025 · AG
Shotgun Lipidomics and Alterations in Sphingolipidomes in Alzheimer's Diseases
$529,887Xianlin Han · Washington University · R01 · FY2007 · AG
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome
$529,653Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2024 · AG
Socioeconomic Mediators of Adult Brain Network Resilience and Vulnerability to Cognitive Decline
$529,596Gagan S Wig · University Of Texas Dallas · R01 · FY2023 · AG
Targeting receptor interacting protein kinase-1 in the chronic period of intracerebral hemorrhage
$529,569Michael J Whalen · Massachusetts General Hospital · R01 · FY2024 · NS
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
$529,502Mohammad Abbas Yaseen · Northeastern University · R01 · FY2020 · AA
Molecular Basis of the Tau Aggregation Pathway
$529,479Songi Han · University Of California Santa Barbara · R01 · FY2017 · AG
Molecular Basis of the Tau Aggregation Pathway
$529,479Songi Han · University Of California Santa Barbara · R01 · FY2019 · AG
Molecular Basis of the Tau Aggregation Pathway
$529,479Songi Han · University Of California Santa Barbara · R01 · FY2018 · AG
Molecular Basis of the Tau Aggregation Pathway
$529,479Songi Han · University Of California Santa Barbara · R01 · FY2020 · AG
Molecular Basis of the Tau Aggregation Pathway
$529,479Songi Han · University Of California Santa Barbara · R01 · FY2021 · AG